FEI establishment
GlaxoSmithKline Biologicals SA
FDA establishment FEI 3002875226 · Rixensart, Belgium
Key facts
| FEI number | 3002875226 |
|---|---|
| Legal name | GlaxoSmithKline Biologicals SA |
| City | Rixensart |
| Country | Belgium |
| Product types | Biologics, Drugs |
| Drug operations | ANALYSIS, LABEL, MANUFACTURE, PACK, STERILIZE |
| Last inspection | Feb 27, 2026 |
At a glance
- 10–99 FDA inspections
- 1–9 No Action Indicated (NAI)
- 10–99 Voluntary Action Indicated (VAI)
- None Official Action Indicated (OAI)
- 10–99 Inspections with a Form 483
- None Citations
- None Repeat citations
- None Warning letters
- None Linked 510(k)s
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA establishments (FEI)
An FEI (FDA Establishment Identifier) is the number the FDA assigns to a site it inspects. FEIs of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection and compliance data